Drug Profile
S 179D-hPRL
Alternative Names: S179D-hPRL; S179D-prolactinLatest Information Update: 14 Jan 2003
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Prolactin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Prostate cancer
Most Recent Events
- 18 Jan 2001 Preclinical development for Prostate cancer in USA (Unknown route)